Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T18:10:53.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the study, with a revised date and a new version number. Additionally, the study now specifies a single location and includes a new informed consent form.
    Difference
    42%
    Check dated 2025-04-16T13:14:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date of 2025-03-25 while adding a new date of 2025-02-14.
    Difference
    0.4%
    Check dated 2025-04-09T05:55:06.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:33:41.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and details regarding the safety of combined drug therapy with radiation therapy, while previous information about toxicity rates and analysis has been removed.
    Difference
    7%
    Check dated 2025-02-17T14:37:24.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:37:59.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.